FIELD: organic chemistry, steroids, vitamins, pharmacy. SUBSTANCE: invention describes novel derivatives of vitamin D3 of the formula (I) where R is -T, F or OH; R2 is H, lower alkyl, halogen atom; X is =CH2 or if R2 is OH then X is (H,H) or =CH2 and A means or -CH2-CH2-. These compounds induce differentiation and inhibit proliferation of cutaneous and cancer cells and can be used, in part, for treatment of patients with hyperproliferative skin diseases, neoplasma diseases, sebaceous gland diseases and states associated with skin damages by light radiation. EFFECT: enhanced effectiveness of treatment and prophylaxis, valuable medicinal properties of compounds. 12 cl, 6 tbl, 38 ex
Title | Year | Author | Number |
---|---|---|---|
D VITAMIN ANALOGS, METHOD OF PREPARING THEREOF, AND PHARMACEUTICAL DRUG | 1994 |
|
RU2134260C1 |
AGENT FOR TREATMENT OF SEBACEOUS GLAND SICKNESS AND PHARMACEUTICAL COMPOSITION BASED ON SAID | 1995 |
|
RU2142803C1 |
TRIAZOLO (4,3-a) 1,4 BENZO DIAZEPINES AND THRENO (3,2 | 1992 |
|
RU2094436C1 |
BETA-LACTAMS | 1995 |
|
RU2143435C1 |
D-PROLINE DERIVATIVES | 1998 |
|
RU2201937C2 |
RETINOIDS AND RETINOID-CONTAINING PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2173683C2 |
SUBSTITUTED PYRROLS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1990 |
|
RU2142460C1 |
3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-c] PYRROLES AS GLUCOKINASE ACTIVATORS | 2011 |
|
RU2603191C2 |
NOVEL RETINOIDS FOR EMPHYSEMA TREATMENT | 2001 |
|
RU2282616C2 |
1,4 THIAZEPINES/SULPHONES AS BACE1 AND/OR BACE2 INHIBITORS | 2012 |
|
RU2600931C2 |
Authors
Dates
2001-09-20—Published
1997-05-23—Filed